Cargando…
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Autores principales: | Guseinova, D, Lazareva, A, Shantere, R, Berzinja, D, Rasnachs, O, Stanevicha, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334129/ http://dx.doi.org/10.1186/1546-0096-6-S1-P67 |
Ejemplares similares
-
Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
por: Lazareva, Arina, et al.
Publicado: (2011) -
HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia
por: Stanevicha, Valda, et al.
Publicado: (2010) -
The role of antibodies to mutated citrulinated vimentin (anti-MCV) in juvenile idiopathic arthritis patients
por: Lamot, L, et al.
Publicado: (2008) -
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
por: Salugina, SO, et al.
Publicado: (2008) -
HLA II class alleles in juvenile idiopathic arthritis patients with temporomandibular joint involvement
por: Davidsone, Zane, et al.
Publicado: (2014)